339 related articles for article (PubMed ID: 17634536)
1. Detection of circulating tumor cells in early-stage breast cancer metastasis to axillary lymph nodes.
Nakagawa T; Martinez SR; Goto Y; Koyanagi K; Kitago M; Shingai T; Elashoff DA; Ye X; Singer FR; Giuliano AE; Hoon DS
Clin Cancer Res; 2007 Jul; 13(14):4105-10. PubMed ID: 17634536
[TBL] [Abstract][Full Text] [Related]
2. Detection of MAGE-A3 in breast cancer patients' sentinel lymph nodes.
Wascher RA; Bostick PJ; Huynh KT; Turner R; Qi K; Giuliano AE; Hoon DS
Br J Cancer; 2001 Nov; 85(9):1340-6. PubMed ID: 11720472
[TBL] [Abstract][Full Text] [Related]
3. Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease.
Taback B; Chan AD; Kuo CT; Bostick PJ; Wang HJ; Giuliano AE; Hoon DS
Cancer Res; 2001 Dec; 61(24):8845-50. PubMed ID: 11751407
[TBL] [Abstract][Full Text] [Related]
4. HER2-positive circulating tumor cells indicate poor clinical outcome in stage I to III breast cancer patients.
Wülfing P; Borchard J; Buerger H; Heidl S; Zänker KS; Kiesel L; Brandt B
Clin Cancer Res; 2006 Mar; 12(6):1715-20. PubMed ID: 16551854
[TBL] [Abstract][Full Text] [Related]
5. Correlation between molecular metastases in sentinel lymph nodes of breast cancer patients and St Gallen risk category.
Gimbergues P; Dauplat MM; Cayre A; Durando X; Le Bouedec G; Finat-Duclos F; Portefaix G; Kwiatkowski F; Dauplat J; Penault-Llorca F; Tchirkov A
Eur J Surg Oncol; 2007 Feb; 33(1):16-22. PubMed ID: 17071045
[TBL] [Abstract][Full Text] [Related]
6. Predictors to assess non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastasis.
Jinno H; Sakata M; Asaga S; Wada M; Shimada T; Kitagawa Y; Suzuki T; Nakahara T; Kitamura N; Kubo A; Mukai M; Ikeda T; Kitajima M
Breast J; 2008; 14(6):551-5. PubMed ID: 19000054
[TBL] [Abstract][Full Text] [Related]
7. A scoring system to predict nonsentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: a comparison with other scoring systems.
Cho J; Han W; Lee JW; Ko E; Kang SY; Jung SY; Kim EK; Moon WK; Cho N; Park IA; Chung JK; Hwang KT; Kim SW; Noh DY
Ann Surg Oncol; 2008 Aug; 15(8):2278-86. PubMed ID: 18528729
[TBL] [Abstract][Full Text] [Related]
8. Distinct hypermethylation profile of primary breast cancer is associated with sentinel lymph node metastasis.
Shinozaki M; Hoon DS; Giuliano AE; Hansen NM; Wang HJ; Turner R; Taback B
Clin Cancer Res; 2005 Mar; 11(6):2156-62. PubMed ID: 15788661
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of the molecular detection of circulating tumor cells using a multimarker reverse transcription-PCR assay for cytokeratin 19, mammaglobin A, and HER2 in early breast cancer.
Ignatiadis M; Kallergi G; Ntoulia M; Perraki M; Apostolaki S; Kafousi M; Chlouverakis G; Stathopoulos E; Lianidou E; Georgoulias V; Mavroudis D
Clin Cancer Res; 2008 May; 14(9):2593-600. PubMed ID: 18451221
[TBL] [Abstract][Full Text] [Related]
10. Possible predictive markers related to micro-metastasis in breast cancer patients.
Zhu L; Loo WT; Cheng CW; Chow LW
Oncol Rep; 2006 May; 15(5):1217-23. PubMed ID: 16596190
[TBL] [Abstract][Full Text] [Related]
11. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
[TBL] [Abstract][Full Text] [Related]
12. Optimal detection of sentinel lymph node metastases by intraoperative radioactive threshold and molecular analysis in patients with melanoma.
Manca G; Romanini A; Pellegrino D; Borsò E; Rondini M; Orlandini C; Zucchi V; Pasqualetti F; Mariani G
J Nucl Med; 2008 Nov; 49(11):1769-75. PubMed ID: 18927334
[TBL] [Abstract][Full Text] [Related]
13. Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer.
Ignatiadis M; Xenidis N; Perraki M; Apostolaki S; Politaki E; Kafousi M; Stathopoulos EN; Stathopoulou A; Lianidou E; Chlouverakis G; Sotiriou C; Georgoulias V; Mavroudis D
J Clin Oncol; 2007 Nov; 25(33):5194-202. PubMed ID: 17954712
[TBL] [Abstract][Full Text] [Related]
14. Multimarker RT-PCR assay for the detection of minimal residual disease in sentinel lymph nodes of breast cancer patients.
Nissan A; Jager D; Roystacher M; Prus D; Peretz T; Eisenberg I; Freund HR; Scanlan M; Ritter G; Old LJ; Mitrani-Rosenbaum S
Br J Cancer; 2006 Mar; 94(5):681-5. PubMed ID: 16495929
[TBL] [Abstract][Full Text] [Related]
15. Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level.
Nowecki ZI; Rutkowski P; Kulik J; Siedlecki JA; Ruka W
Br J Dermatol; 2008 Sep; 159(3):597-605. PubMed ID: 18616789
[TBL] [Abstract][Full Text] [Related]
16. Prediction of breast tumor progression by integrity of free circulating DNA in serum.
Umetani N; Giuliano AE; Hiramatsu SH; Amersi F; Nakagawa T; Martino S; Hoon DS
J Clin Oncol; 2006 Sep; 24(26):4270-6. PubMed ID: 16963729
[TBL] [Abstract][Full Text] [Related]
17. Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients.
Langer I; Guller U; Hsu-Schmitz SF; Ladewig A; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
Eur J Surg Oncol; 2009 Aug; 35(8):805-13. PubMed ID: 19046846
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of bone marrow micrometastases with sentinel lymph node status in early-stage breast cancer.
Saha S; Ali S; Ghanem M; Soni M; Wiese D; Arora M; Singh T; Iddings D
Ann Surg Oncol; 2009 Feb; 16(2):276-80. PubMed ID: 19050967
[TBL] [Abstract][Full Text] [Related]
19. Association of the presence of bone marrow micrometastases with the sentinel lymph node status in 410 early stage breast cancer patients: results of the Swiss Multicenter Study.
Langer I; Guller U; Koechli OR; Berclaz G; Singer G; Schaer G; Fehr MK; Hess T; Oertli D; Bronz L; Schnarwyler B; Wight E; Uehlinger U; Infanger E; Burger D; Zuber M;
Ann Surg Oncol; 2007 Jun; 14(6):1896-903. PubMed ID: 17356955
[TBL] [Abstract][Full Text] [Related]
20. Molecular analysis improves sensitivity of breast sentinel lymph node biopsy: results of a multi-institutional prospective cohort study.
Mikhitarian K; Martin RH; Mitas M; Mauldin PD; Palesch Y; Metcalf JS; Cole DJ; Gillanders WE;
Surgery; 2005 Sep; 138(3):474-81. PubMed ID: 16213901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]